Vetoryl 10 mg 10 mg Capsule is a Health Canada–registered veterinary drug (DIN 02322005) held by Dechra Ltd, containing Trilostane. Health Canada lists its status as Marketed (status date 25 Jun 2009). Nexara Health has matched 28 registrations of Trilostane across 6 other regulated markets.

Health Canada registration

Trilostane registered in other markets

28 registrations of the same molecule in 6 national registries outside Canada (first 24 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Trilostane worldwide →

Regulator price references for Trilostane

Published list or reimbursement prices for Trilostane presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Marketed Canadian products with the same active ingredient

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Vetoryl 10 mg (DIN 02322005) marketed in Canada?

Yes. Health Canada lists DIN 02322005 as Marketed as of 25 Jun 2009.

Who holds the Canadian licence for this product?

Dechra Ltd is the company of record in the Health Canada Drug Product Database.

Is Trilostane registered outside Canada?

Yes — Nexara Health has matched 28 registrations in 6 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02322005, status date 2009-06-25; national medicine registries: EMA centrally authorised, FDA NDC, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, TFDA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02322005, status date 2009-06-25; national medicine registries: EMA centrally authorised, FDA NDC, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, TFDA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.

Health Canada Drug Product Database (DPD), DIN 02322005, status date 2009-06-25; national medicine registries: EMA centrally authorised, FDA NDC, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, TFDA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.